Cell Free DNA in Mature B-cell Lymphoma

Shanghai Jiao Tong University

Status: Enrolling

Conditions: Mature B-Cell Lymphoma

Treatments: Procedure: peripheral blood collection

Study type: Observational

Funder types: Other

Identifiers

NCT04088422

cfDNA

Details and patient eligibility

About

The purpose of this study is to assess whether plasma cell free DNA is an accurate tool that can early and dynamically inform on treatment outcome and an accessible source of tumor DNA to track tumor clonal evolution.

Enrollment: 320 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Documented diagnosis of mature B-cell tumor according to WHO 2008 criteria
• 18 years or older

Exclusion criteria

• Chemotherapy before
• Other tumors

Trial design

320 participants in 1 patient group

B-cell lymphoma

Treatment:

Procedure: peripheral blood collection